PRP in Ophthalmology: An Emerging Area of Study
Publish date: September 2, 2026
Introduction: A New Frontier for PRP
PRP in ophthalmology has become a growing area of study over the past several years. The eye’s surface heals in a delicate, highly specialized environment, so researchers have started to ask whether platelet-rich plasma’s concentrated growth factors could support existing treatment approaches for certain ocular surface conditions.
This article covers where PRP in ophthalmology stands today, what the research shows, and what eye care practices should weigh before they explore this application.
Where PRP in Ophthalmology Is Being Studied
Researchers and eye care providers have looked at PRP in a few specific contexts, including:
- dry eye disease and ocular surface support
- persistent corneal epithelial defects
- post-surgical healing following certain corneal procedures
- autologous serum and plasma-based eye drop preparations
Because the eye’s surface is thin and sensitive, any PRP-based approach in ophthalmology requires careful preparation and handling. As a result, this application looks quite different in practice from PRP use in orthopedics or aesthetics, even though the underlying biology is related.
What the Research Says
Research on PRP in ophthalmology continues to develop, and findings vary by condition and preparation method. For example, clinicians can review relevant studies via PubMed. In addition, background on the ocular surface and tear film can be found through the National Library of Medicine’s overview of the ocular surface, NCBI.
Because ophthalmic applications often require a different preparation format than injectable PRP, such as eye drops derived from plasma, study protocols vary widely. Therefore, practitioners generally review the specific preparation method used in a given study before drawing conclusions for their own practice.
What Eye Care Practices Should Evaluate
Before a practice explores PRP in ophthalmology, it typically weighs a few factors:
- whether the intended use calls for an injectable, drop, or topical preparation format
- staff training needs for a new preparation and handling protocol
- sterility and handling requirements specific to ophthalmic use
- how the practice will document and explain this option to patients
Because ophthalmic tissue handling carries its own specific protocols, practices considering this application often coordinate closely with their compounding or preparation partners before adoption.
Where Tropocells® PRP Fits
The Tropocells® PRP system’s single-spin design supports a controlled, repeatable separation process, which practices can build on as they establish protocols for newer applications. Because the underlying preparation stays consistent, an eye care practice exploring PRP can rely on the same core system it may already use elsewhere.
Learn more: Tropocells® PRP
Conclusion
PRP in ophthalmology remains an early but growing area of study. Therefore, eye care practices that consider this application benefit from reviewing the current research, confirming the right preparation format for their intended use, and talking through protocols with their clinical and compounding partners before they move forward.
Note: this content serves educational purposes only and does not offer medical advice. FDA regulations apply to platelet-rich plasma preparation devices; check current regulatory guidance and product labeling for intended use information.